Agilent: Margin Expansion Meets a Replacement Cycle That Management Already Accelerated

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Agilent typically reports after market close, meaning Day 0 reflects anticipation before results are released, while Day +1 captures the market's first full reaction to the earnings announcement.

Agilent's post-earnings price behavior shows significant volatility, with an average absolute Day +1 move of 4.43% and an average Day +1 range of 6.07%. The most dramatic reaction came after the May 2026 report, when the stock surged 16.87% on Day +1 following a strong earnings beat. Other notable moves include a 5.28% gain in August 2025 and a -5.50% decline in February 2025, highlighting the stock's sensitivity to earnings results and guidance.

Day 0 moves are typically muted, averaging just 0.50%, consistent with after-hours reporting where anticipation builds but the market hasn't yet digested results. The Day +1 range of 6.07% suggests investors should prepare for meaningful intraday swings as the market processes the report and management commentary. The historical pattern indicates that positive surprises—particularly on guidance—can drive outsized gains, while disappointments or cautious outlooks can trigger sharp selloffs.

Part 2.2: Options Market Expected Move

The options market is pricing a 6.92% expected move for the September 18 expiration, which is notably higher than the average historical Day +1 move of 4.43% but in line with the 6.07% average Day +1 range. This suggests options traders are anticipating above-average volatility, possibly reflecting uncertainty around guidance or end-market commentary.

Part 3: What Analysts Are Saying

Analysts maintain a bullish stance on Agilent heading into earnings, with an average recommendation of 4.40 out of 5.00—firmly in buy territory. The consensus includes 13 Strong Buys, 2 Moderate Buys, and 5 Holds, with no sell ratings. This reflects broad confidence in the company's growth trajectory and execution capabilities.

Sentiment has remained unchanged over the past month, with the rating distribution holding steady at 13 Strong Buys, 2 Moderate Buys, and 5 Holds. The stability suggests analysts are comfortable with their current views and are awaiting the Q3 report to reassess.

The average price target stands at $160.00, implying 3.38% upside from the current price of $154.77. The range of targets spans from a low of $148.00 to a high of $185.00, with the upper end reflecting optimism around Agilent's ability to capitalize on growth opportunities in life sciences and diagnostics. The modest implied upside suggests the stock is trading near fair value based on current expectations, with the earnings report serving as a potential catalyst for a re-rating if results and guidance exceed consensus.

Part 4: Technical Picture

Agilent enters earnings with strong technical momentum. The Barchart Technical Opinion currently stands at 88% Buy, unchanged from last week but up from 72% Buy a month ago, signaling sustained bullish sentiment. The stock is trading above its 10-day ($152.19), 20-day ($147.24), 50-day ($138.50), 100-day ($129.33), and 200-day ($131.38) moving averages, though it sits slightly below the 5-day moving average ($155.78), suggesting a minor near-term pullback within an otherwise upward trend.

Timeframe Analysis:

• Short-term (100% Buy): Strong buy signal indicates near-term momentum is decisively positive, with the stock well-positioned heading into the earnings event.
• Medium-term (100% Buy): Continued strength in the intermediate timeframe reflects sustained upward pressure and investor confidence.
• Long-term (50% Buy): Moderate buy signal suggests the longer-term trend remains constructive but less emphatic than shorter timeframes.

Trend Characteristics: The trend is characterized as Strong and Strengthening, indicating that momentum is not only robust but accelerating into the earnings release—a supportive backdrop for a positive reaction if results meet or exceed expectations.

The stock's position above all major moving averages except the 5-day reflects a healthy uptrend with minor near-term consolidation. The 50-day moving average at $138.50 has provided strong support, while the recent climb above $154 suggests buyers remain in control. With the stock trading near the upper end of its 52-week range ($108.35–$160.51) and technical indicators aligned bullishly, the setup is supportive heading into earnings. However, the elevated technical positioning also means the stock has less room for disappointment—any miss or cautious guidance could trigger profit-taking given the strong run-up.